(6-Aminopyridin-3-yl)boronic acid hydrochloride, 95.0%, 5g

1-(propan-2-yl)piperidine-2-carboxylic acid hydrochloride, 95.0%, 500mg

2-Amino-3-nitrobenzoic acid methyl ester, 98.0%, 100g

GC capillary column ROTI®Cap-5, 10 m, 0.32 mm, 0.10 µm, 1 Piece(s)

6-(dimethylamino)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 95.0%, 2.5g

3-Azetidinecarboxylic acid, 96.0%, 25g

N-(2-((5-Chloro-2-((2-methoxy-4-morpholinophenyl)amino)pyrimidin-4-yl)amino)phenyl)methanesulfonamide, 98%, 25mg

ETHYL 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-5-CARBOXYLATE, 95.0%, 500mg

4-(3-chlorophenyl)-3-methyl-1H-pyrazol-5-amine hydrobromide, 95.0%, 250mg

2-Amino-3,5-dichloro-4-methylpyridine>98.0%(GC)(T)1g

(1r,1's,4R,4'R)-4-Ethoxy-4'-propyl-1,1'-bi(cyclohexane), 95.0%, 5g

3-PHENYL-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE, 97.0%, 250mg

7-(3,4-Dimethoxyphenyl)-7-oxoheptanoic acid, 97.0%, 2g